A combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts is able to improve sexual quality of life in patient with premature ejaculation

• Published in: Archivio italiano di urologia, andrologia Vol. 88; no. 3; p. 171
• Main Authors: Sansalone, Salvatore, Russo, Giorgio Ivan, Mondaini, Nicola, Cantiello, Francesco, Antonini, Gabriele, Cai, Tommaso
• Format: Journal Article
• Language: English
• Published: Italy 05.10.2016
• Subjects: Administration, Oral; Adult; Behavior Therapy - methods; Drug Combinations; Follow-Up Studies; Humans; Male; Phyllanthus emblica - chemistry; Plant Extracts - administration & dosage; Plant Extracts - therapeutic use; Premature Ejaculation - drug therapy; Quality of Life; Satureja - chemistry; Surveys and Questionnaires; Treatment Outcome; Tribulus - chemistry; Tryptophan - administration & dosage; Tryptophan - therapeutic use; Young Adult
• DOI: 10.4081/aiua.2016.3.171
• ISSN: 1124-3562

The management of patient affected by premature ejaculation (PE) is nowadays not highly satisfactory. Here, we aimed to evaluate the tolerability and efficacy of a combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts in order to improve sexual quality of life in patients with premature ejaculation. All patients attending to 5 urological centers from January 2015 to March 2015, due to premature ejaculation were enrolled in this study. At the enrolment visit, all subjects underwent self-administered IIEF-5, Male Sexual Health Questionnaire-Ejaculation Disorder (MSHQEjD), PEDT and IELTS (calculated as mean from that perceived by partner and that perceived by patient) and underwent urological visit and laboratory examinations. All patients received one tablet per day of a combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts for 3 months (Group A). After 3 months all patients underwent follow-up visit with the same investigations that have been carried out in the enrolment visit. The results were compared with a cohort of patients enrolled in the same period in another urological center and considered as a control group (Group B). All patients in the control group underwent counseling and sexual behavioral treatment without any pharmacological compound. At the follow-up analysis, significant changes in terms of IELT in the Group A (mean difference: 31.90; p < 0.05) at 3 months and versus Group B at the intergroup analysis (mean difference: 30.30; p < 0.05) were reported. In the group A, significant differences from baseline to last follow- up were observed relative to IIEF-5 (mean difference: 1.04; p < 0.05), PEDT (mean difference: -2.57; p < 0.05) and FSH (mean difference: -16.46; p < 0.05). In conclusion, patients affected by PE may significantly benefit from oral therapy with a combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts in terms of IELT and PEDT scores improvement.